Why it matters:
A loophole in the 2018 Farm Bill has allowed hemp-derived cannabinoids, such as Delta-8 THC and THC-O, to be produced and sold legally. This has created a new market for these compounds, which are being used in various consumable products. However, there is still limited knowledge about the effects and safety of these compounds.
What they are saying:
According to industry insiders, the distinction between hemp and marijuana is mostly arbitrary, as they are essentially the same plant. The Farm Bill’s legalization of hemp has opened up opportunities for the extraction and isolation of various compounds from the cannabis plant. These compounds, known as HDCs, are created through chemical processes and can provide different effects.
The big picture:
The emergence of HDCs has raised questions about regulation and safety. Industry experts are calling for federal regulations to ensure the safety and effectiveness of these products. The comparison is also made to synthetic cannabinoids, which have had harmful effects in the past. However, HDCs differ from synthetic cannabinoids as they are derived from the cannabis plant itself.
What to watch:
The DEA and FDA are expected to release regulations and rules regarding HDCs, including Delta-8 THC. The federal government’s actions will ultimately determine how the market for these compounds evolves. The merging of the legal hemp market and state cannabis markets is also anticipated, but the outcome will depend on federal decisions.
My take:
The legalization of hemp-derived cannabinoids has created a new market, but there are still uncertainties regarding the effects and safety of these compounds. It is crucial for federal regulations to be put in place to ensure consumer safety and the quality of these products. The merging of different markets will require careful consideration and regulation.
